Drugs / Sulfentanil
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable1 trial | ||||||
| — | NCT04553536 | Nov 2020 → Jun 2023 | poisoning | Second Hospital of Shanxi Medical University | Unknown | No outcome recorded |
| Comparator or background therapy3 trials | ||||||
| — | NCT07112157 Comparator | Aug 2025 → Aug 2026 overdue | strabismus | Henan Provincial People's Hospital | Not yet recruiting | No outcome recorded |
| — | NCT06668298 Comparator | Nov 2024 → Jun 2025 overdue | — | Henan Provincial People's Hospital | Not yet recruiting | No outcome recorded |
| — | NCT02799797 Background | Jul 2016 → Feb 2018 | — | Cui Xulei | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | sulfentanil | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02799797 ↗ |
| Route | Intravenous | “sufentanil was injected intravenously” NCT07112157 ↗ |